Chamath: Nancy Pelosi's returns are so good because Reg FD does not apply to people in Congress
Chamath Palihapitiya argues that Nancy Pelosi's exceptional investment returns are due to Regulation FD (Fair Disclosure) not applying to members of Congress, allowing them to trade on information learned in committee meetings. He contends this constitutes a structural advantage unavailable to ordinary investors and calls for reform.
Summary
In this brief clip, Chamath Palihapitiya and others discuss the remarkable investment returns attributed to Nancy Pelosi, noting that her performance over decades is described as 'generational' and even superior to Warren Buffett's. The group finds humor in this observation before Chamath offers his central thesis: that Pelosi's returns are not the result of investment genius but rather a structural legal loophole.
Chamath explains that Regulation FD (Fair Disclosure), which prohibits corporate insiders and others from selectively disclosing material non-public information to certain investors, does not apply to members of Congress. This means that information disclosed during congressional committee meetings — which could include sensitive details about companies, industries, or upcoming legislation — can legally be acted upon by members of Congress through their personal trades.
The participants express concern about this practice, with at least one voice calling for it to be stopped. The clip ends mid-sentence, suggesting this was part of a longer conversation about Congressional trading ethics and the need for reform.
Key Insights
- Chamath argues that Nancy Pelosi's investment returns are so consistently strong that they surpass Warren Buffett's performance over decades, describing them as 'generational.'
- Chamath claims that Regulation FD — the SEC rule requiring fair and equal disclosure of material information — does not apply to members of Congress, giving them a legal advantage in trading.
- Chamath asserts that members of Congress can learn material, market-moving information during committee meetings and legally trade on it, something that would be illegal for corporate insiders or Wall Street professionals.
- Chamath explicitly states that there are situations where information is disclosed in congressional settings and members are then actively trading in real time based on that information.
- The group collectively implies that this loophole should be closed, with one participant stating 'we got to stop them,' framing Congressional trading on committee information as a systemic problem requiring legislative action.
Topics
Transcript
[0:00] to put up the kind of returns that Nancy Pelosi has done over decades is nothing short of miraculous. >> It's generational. >> She's substantially better than Warren Buffett. [laughter] >> The reason why Nancy Pelosy's returns are so consistently good is reggd does not apply to people in Congress. That should be the takeaway. They can learn things. >> We got to stop them. >> They can learn things in their committee meetings. In fact, there are situations where things are disclosed and then they are trading in real
Full transcript available for MurmurCast members
Sign Up to AccessMore from All-In Podcast
Chamath: 3 Things Every Company Needs in the Age of Superintelligence
Chamath outlines three critical requirements for companies deploying superintelligence: end-to-end traceability to understand operations, mapping policies to risks, and maintaining audit evidence for accountability. He argues these practical governance measures are superior to delaying AI deployment through multinational regulation.
Jake Paul & The Chainsmokers: Turning Fame into Funds, Jake Enters Politics? & Venture Bubble Signs
A wide-ranging discussion featuring Jake Paul on entrepreneurship, boxing, and venture capital, followed by The Chainsmokers discussing their evolution from music producers to serious venture investors. Both segments explore how entertainment figures leverage fame and attention into sustainable business empires.
Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential
Daniel Ek, Spotify's co-founder and now executive chairman, discusses his transition to healthcare through his new company Neko, which offers comprehensive preventive health screening for $499. The conversation covers Spotify's founding challenges, healthcare system incentive problems, and AI's potential in medical diagnostics and beyond.
Jason Calacanis: AI Is About to “Blow People’s Minds”
Jason Calacanis argues that AI products like Grok and Muse are reaching a tipping point where average consumers can derive real, tangible benefits for everyday tasks. He predicts that by year-end, ordinary people will adopt these tools as free personal assistants, marking a significant moment in AI democratization that could benefit lower-income Americans.
Jason Calacanis: Dario Seems to Be Sabotaging His Own IPO
Jason Calacanis critiques Anthropic CEO Dario Amodei for actions that appear to undermine the company's IPO prospects, specifically opening a lab after citing existential AI risks. Calacanis argues this represents a failure of leadership and suggests the board should replace the CEO with someone focused on running the company rather than sabotaging it.